INTRODUCTION
The expansion of repeat sequences beyond a pathogenic threshold is the causative mutation mechanism in over 20 dominantly inherited neurodegenerative diseases including Huntington's disease (HD) and several spinocerebellar ataxias (SCAs) (1, 2) . The genes that carry repeat sequences in each of these diseases are otherwise unrelated but give rise to similar late-onset progressive neurodegeneration and disease severity correlates with the length of the expanded repeat. A number of these diseases are caused by the expansion of CAG n trinucleotide repeats within the coding region of affected genes. Such expansions result in the production of a protein containing an expanded polyglutamine tract that is thought to be the causative agent for neuronal dysfunction and atrophy in specific regions of the brain.
In addition to these translated repeat sequences encoding polyglutamine, expansion of repeat sequences can also be found in untranslated regions of genes. The expansion of untranslated tri-, tetra-, penta-or hexanucleotide repeats has been identified as the mutations leading to the dominantly inherited myotonic dystrophy type 1 and 2 (DM1 and DM2), HD-like-2 (HDL-2), fragile X tremor ataxia syndrome (FXTAS) and SCA 8, 10, 12, 31 and 36 (3) (4) (5) . Furthermore, an expanded hexanucleotide repeat has recently been characterized to lead to a substantial proportion of cases of frontotemporal dementia and amyotrophic lateral sclerosis (6, 7) . The striking similarity of phenotypic outcomes in several instances between translated and untranslated repeat diseases and typical features of late-onset dominant inheritance suggest the possibility of a common pathogenic mechanism (Supplementary Material, Fig. S1 ). Expanded repeat-containing RNA is common to each of these diseases and has therefore been * To whom correspondence should be addressed at: Molecular Life Sciences Building, The University of Adelaide, Adelaide SA 5005 Australia. Tel: +61 883037541; Fax: +61 883037534; Email: robert.richards@adelaide.edu.au hypothesized as a common pathogenic agent (8) (9) (10) (11) (12) (13) . Various experimental approaches have been undertaken in animal models to define the physical properties of the RNA which are necessary and sufficient for toxicity and the downstream pathways that contribute to pathogenesis. A number of distinct mechanisms by which RNA can cause pathogenesis have been described.
First, expanded repeat-containing single-stranded RNAs form RNA secondary structures that recruit and sequester RNAbinding proteins such as Muscleblind, resulting in the loss of function of these proteins, and in doing so contribute to pathogenesis (14) . Second, a recent study demonstrates that hairpin repeat RNA can act as an internal ribosomal entry site to enable repeat-associated non-ATG (RAN) initiated translation of expanded repeat-containing RNA (15) . Therefore, toxicity of translated homopolymeric peptides must be considered (16) . Third, recent reports demonstrate that expanded repeatcontaining genes are often transcribed from both strands, a phenomenon termed bidirectional transcription. The products of this transcription are predicted to form perfectly paired doublestranded RNA (17 -20) . This double-stranded RNA has, in turn, been shown to be capable of toxicity via various mechanisms including recruitment of histone modifiers and/or perturbation of transcriptional regulation through effects on CTCF-binding sites that flank the repeat sequences (17, 21) , or a Dicerdependent mechanism (11, 12) .
We have previously described Drosophila models of expanded repeat diseases that specifically investigate the intrinsic toxicity of both translated and untranslated expanded repeat sequences (9, 10, 13, 16) . Bidirectional transcription was modeled by co-expression of expanded rCAG 100 together with rCUG 100 (rCAG.rCUG 100 or dsRNA) to produce repeatcontaining double-stranded RNA (11) . Flies expressing dsRNA showed Dicer-dependent toxicity. Additionally dsRNA expression throughout the nervous system caused an age-dependent neurodegenerative phenotype. An abundance of rCAG 7 also implicated specific Dicer processing of the rCAG.rCUG 100 as a pathogenic pathway in this model (11) . Similar findings have also been reported in an independent Drosophila model (12) . Furthermore, an altered endogenous miRNA profile was observed. Examination of HD patient samples revealed the presence of similar rCAG 7 (22) providing evidence in support of the activity of this pathway in HD pathogenesis.
In an effort to identify further components of expanded repeat RNA pathogenesis in Drosophila, we have undertaken microarray analysis of Drosophila expressing rCAG.rCUG 100 repeat RNAs. Changes in transcription profiles reveal candidate pathways for mediating resultant pathogenesis. Alterations in transcripts common to several pathways were detected, including components of innate immunity. Hallmarks of immune activation appear prior to clinical symptoms of dominantly inherited expanded repeat human diseases (23, 24) . Therefore, we have used a Drosophila model to test two key elements of immune activation; the Toll and autophagy pathways for their contribution to expanded repeat RNA pathogenesis. We have identified that the Toll signaling pathway is essential for doublestranded RNA pathogenesis, and that autophagy reduces toxicity in this model.
RESULTS
Identification of candidate pathways contributing to rCAG.rCUG ∼100 repeat RNA pathogenesis in Drosophila Microarray analysis was performed using Affymetrix Drosophila 2.0 arrays. RNA was extracted from heads of 1-day old male Drosophila expressing double-stranded RNA with the pan-neuronal driver elavII-GAL4 (25) . Two independent dsRNA lines, rCAG.rCUG 100
S1
and rCAG.rCUG 100 S2 , were analyzed to identify robust changes caused by the expression of dsRNA and minimize any changes simply due to site of transgene insertion effects. These changes were compared with a control with no repeat expression (4xUAS). Each genotype was analyzed with triplicate samples to account for biological variation. The repeat expression levels of each dsRNA line used in this experiment were analyzed by a quantitative PCR (Supplementary Material, Fig. S2 ). Repeat expression in the rCAG.rCUG 100
S2
triplicates was lower than that of rCAG.rCUG 100
S1
and is consistent with the phenotypic severity observed in the eye (11) .
Two approaches were utilized to identify possible pathways contributing to dsRNA pathogenesis. The first was to identify transcripts exhibiting the most significant quantitative changes as a result of rCAG.rCUG 100 repeat RNA expression. In order to determine expression changes caused by doublestranded RNA, genes that showed a significant change in each of the dsRNA lines (rCAG.rCUG 100 S1 or rCAG.rCUG 100 S2 ) compared with the control (4xUAS) (P , 0.05) but were unchanged between each other (P ≥ 0.05) were examined. Altered transcripts were further filtered for those that gave a log2 of the expression ratio-defined as log2 (ratio)-of .+1 or ,21, that is the genes with a greater than +2-fold change in expression (Supplementary Material, Table S1 ). The altered transcripts were grouped into particular pathways based on their function and potential role in pathogenesis (Fig. 1) .
Second, the data generated from this microarray analysis was searched for genes which contain a CUG or CAG repeat tract (complementary to repeat-derived CAG or CUG small RNA respectively) and thus are potential targets of rCAG.rCUG 100 Dicer cleavage products. Transcripts that showed a significant change in abundance (P , 0.05) between both rCAG.rCUG 100 lines and the 4xUAS control were obtained. In this case the data was not filtered for a minimum fold change difference (log2 (ratio)) in expression. None of the transcripts with a significant change in abundance contained a CUG repeat tract. On the other hand, 13 transcripts containing seven or more tandem CAG repeats show a significant change in expression in the presence of rCAG.rCUG 100 (Supplementary Material, Table S2 ).
Several of the transcripts that were significantly altered were involved in various components of innate immunity. Evidence in the literature of elevated cytokine levels and microglia activation in dominant expanded repeat diseases (23, 24) , together with the significant alteration of the Drosophila NFkB ortholog, dorsal, led to further investigation of the Toll pathway in double-stranded RNA-mediated pathogenesis.
2812
Human Molecular Genetics, 2013, Vol. 22, No. 14 Double-stranded RNA-mediated toxicity is dependent on activation of the Toll pathway
The external surface of the Drosophila eye consists of precisely patterned ommatidia. Ectopic expression of expanded repeat sequences in the eye using the GAL4/UAS expression system has been used to study expanded repeat disease pathogenesis (26) (27) (28) (29) (30) (31) . Expression of rCAG.rCUG 100 in differentiated cells of the eye using the GMR-GAL4 driver (32) causes disruption to ommatidial patterning and some loss of pigmentation (see Fig. 2A versus A ′ ). A modification of the dsRNA phenotype was indicative of a functional interaction between the candidate protein and double-stranded RNA. The expression levels were altered using conditional gene inactivation in the Drosophila eye by RNAi knockdown of each individual gene (33, 34) . The RNAi lines used in this experiment have no predicted off-target effects, are expressed from specific insertion sites in the Drosophila genome (to prevent variable expression) and are flanked by gypsy insulator sequences to increase the level of expression (34) . Expression of control dsRNA (LacZ RNAi ) (35) in the eye gave no phenotype (Supplementary Material, Fig. S3 ).
Nine Toll receptors are present in Drosophila. Of these, seven Toll receptors: Tl, 18-wheeler (18W), MstProx, Toll-4, Toll-7, Tollo and Toll-9, were individually reduced in the Drosophila eye by RNAi using GMR-GAL4 (32). In each case of RNAi knockdown of Toll receptors alone, no effect on ommatidial patterning was observed and eyes appeared similar to the expression of the control mCherry RNAi , which does not have an endogenous target ( Fig. 2A -H) . Knockdown of Tl in flies also expressing rCAG.rCUG 100 has a mild effect on pigmentation ( Fig. 2B ′ versus A ′ ), whereas knockdown of 18W, MstProx, Toll-4, Toll-7, Tollo and Toll-9 significantly suppressed the rCAG.rCUG 100 double-stranded RNA repeat induced rough eye and loss of pigmentation phenotype observed in the mCherry control ( Fig. 2C ′ -H ′ versus A ′ ). These findings suggest that various receptors of Toll signaling contribute to rCAG.rCUG 100 double-stranded RNA toxicity.
In addition, several different protein components of the Toll pathway (Supplementary Material, Fig. S4 ) were also individually decreased by RNAi to further assess the participation of this pathway in double-stranded RNA toxicity. Knockdown of spatzle (spz), the receptor ligand, resulted in significant suppression of the rCAG.rCUG 100 phenotype seen with expression of mCherry RNAi control (Fig. 3B ′ versus A ′ ). Knockdown of pelle (pll) caused a mild effect with reduced black necrotic regions and disruption to patterning (Fig. 3C ′ ). The knockdown of cactus (cact) had no detectable effect on the rCAG.rCUG 100 phenotype (Fig. 3D ′ ). Due to the negative regulatory role of cactus in the Toll pathway, reduced levels of cactus were expected to enhance the rCAG.rCUG 100 phenotype. The lack of an enhancement may be attributed to a threshold, in which reducing cactus levels does not activate the Toll pathway more than that caused by degradation of endogenous cactus. Knockdown of dorsal (dl), however, resulted in significant suppression of the rCAG.rCUG 100 phenotype (Fig. 3E ′ ). In each case, knockdown of each gene alone did not cause any phenotype in the eye (Fig. 3A -E) .
These experiments provide evidence that reduction of Toll pathway proteins suppresses rCAG.rCUG 100 double-stranded RNA toxicity, indicating that inhibition of a Toll-mediated response reduces pathogenesis. This demonstrates that repeatcontaining double-stranded RNA toxicity is dependent on the activation of the Toll pathway.
The Toll pathway is activated in the presence of repeat-containing double-stranded RNA in Drosophila Drosomycin is a classic antimicrobial peptide activated by Toll signaling and is widely used as a functional readout of this pathway (36) . The expression level of Drosomycin was assessed to determine if a Toll-mediated response was activated in this dsRNA model. A quantitative PCR was performed to determine the transcript levels in flies that pan-neuronally (elavII-GAL4 (ref 25)) express rCAG.rCUG 100 . These flies showed a 1.7-fold increase (P ¼ 0.0034) in Drosomycin expression levels compared with control flies expressing no expanded repeats (Fig. 4A) . A similar elevation of Drosomycin has previously been observed with induction of an immune response via the Toll pathway (37) (38) (39) . The initiation of an inflammatory response was determined by measuring the transcript levels of the Drosophila TNF homologue, Eiger (40) . A quantitative PCR of flies expressing rCAG.rCUG 100 in neurons (elavII-GAL4 25 ) showed a 1.4-fold increase (P ¼ 0.0043) in Eiger expression levels compared with control flies (Fig. 4B ).
These findings demonstrate the activation of the Toll pathway in response to ectopic expression of repeat-containing double-stranded RNA. Furthermore, expression of double- stranded RNA activates innate immunity, suggesting that rCAG.rCUG 100 causes an immune response similar to that observed in neurodegenerative disease.
Double-stranded RNA toxicity in glial cells leads to neurodegeneration
Toxicity in glial cells, the immune cells of the nervous system, has previously been shown to lead to neurotoxicity (41) (42) (43) (44) (45) . Double-stranded RNA was expressed in glial cells to determine its contribution to neuronal dysfunction in this model. Glial expression of rCAG.rCUG 100 with repo-GAL4 (46) was highly toxic and led to lethality in strong expression lines. Therefore, two weaker rCAG.rCUG 100 lines, rCAG.rCUG 100 W1 and rCAG.rCUG 100 W2 , containing 1xrCAG 100 and 1xrCUG 100 were used. Substantial lethality was also observed with these lines and hence, only a small sample size was used for the experiment. The climbing ability of flies expressing these weak rCAG.rCUG 100 lines was scored to determine neuronal function, using the method described previously (11) .
An average of 53.34 and 42% of flies expressing rCAG.rCUG 100
W1
and rCAG.rCUG 100
W2
showed 'failure to climb' at week 1 compared with 8.57% control flies, demonstrating a significant climbing defect (P , 0.0001 in each case) (Fig. 5) . The same flies aged for another week showed further exacerbation of the climbing defect. At week 2, an average of 96 and 76.25% of flies expressing rCAG.rCUG 100
W1
W2
showed a 'failure to climb' compared with 21.54% control flies (P , 0.0001 in each case) (Fig. 5) . Statistical analysis also demonstrated a significant effect on the climbing ability of flies expressing rCAG.rCUG 100 W1 and rCAG.rCUG 100 W2 between weeks 1 and 2 demonstrating agedependent progressive deterioration of (P , 0.001 in each case) neuronal function due to toxicity in glial cells. An age-dependent effect was not observed in the control flies (P ¼ 0.1227).
The neuronal dysfunction observed with glial expression of rCAG.rCUG 100 indicates the potential for human neurodegenerative disease phenotypes to be caused by toxicity that is not cell-autonomous, given that the relevant human disease genes are usually not restricted in their expression to specific cell types.
Autophagy restricts double-stranded RNA toxicity
Autophagy activation is a key element of the inflammatory response (47) . To investigate the role of autophagy in repeatcontaining double-stranded RNA toxicity, the level of two autophagy specific genes (Atg) was reduced by RNAi in the Drosophila eye. Knockdown of Atg1 or Atg18 alone had no effect on the Drosophila eye ( Fig. 6B and C) . These eyes appeared similar to a control with the GMR-GAL4 driving a UAS construct with no RNAi (Fig. 6A) . Knockdown of either Atg1 or Atg18 in flies also expressing rCAG.rCUG 100 caused an enhancement of the dsRNA phenotype (Fig. 6B ′ and C ′ ). These eyes showed an increase in the rough eye phenotype and also showed some necrosis compared with the rCAG.rCUG 100 alone (Fig. 6A ′ ). These results indicate that autophagy is necessary for clearing the toxicity caused by the double-stranded RNA and is therefore restrictive of toxicity.
DISCUSSION
The specific mechanism(s) through which dynamic mutations lead to pathogenesis in the dominantly inherited, expanded repeat diseases is/are not fully understood. The degeneration and loss of susceptible tissues and cells in affected individuals have made the study of pathogenic mechanisms in primary tissues extremely difficult, since these somatic targets are no longer available in those whose death occurs in the latter stages of the disease. The use of model organisms such as Drosophila circumvents this problem. Specifically in the case of Drosophila, expanded repeat toxicity can be modeled in a tissue specific manner with the GAL4/UAS 2814 Human Molecular Genetics, 2013, Vol. 22, No. 14 system. This permits the analysis and dissection of potential pathogenic mechanisms without affecting the rest of the organism. We have used this system to model complementary double-stranded RNA toxicity as a potential pathogenic pathway in these diseases.
In this study, we identify activation of the innate immune system as a component of double-stranded RNA-mediated toxicity. The data presented herein showed that the Toll pathway is activated in the presence of repeat-containing double-stranded RNA and toxicity is dependent on this pathway. Normally, endogenous RNAs are shielded from Toll pathway activation as part of the mechanism to distinguish 'self' from 'non-self' RNAs (48) . This typically involves post-transcriptional modification or editing of the RNA. Therefore, it is likely that rCAG.rCUG 100 repeat-containing double-stranded RNA has some property that interferes with this mechanism.
Interestingly, several miRNAs altered in this Drosophila double-stranded RNA model (11) are known to influence Drosophila immunity, including the Toll pathway (49) . Furthermore double-stranded RNA toxicity in glial cells causes neurodegeneration, suggesting that non-autonomous toxicity is sufficient for neuronal dysfunction. In addition, we have also uncovered a protective role for autophagy in double-stranded RNA toxicity. This restrictive effect of autophagy on toxicity is consistent with previous findings in polyglutamine disease models (50) (51) (52) . These findings suggest that the homeostatic balance between the activation of the Toll pathway by doublestranded RNA and induction of autophagy as a defence response may be critical to pathogenic progression. Together, these data identify a novel mechanism through which repeat-containing double-stranded RNAs cause pathogenesis (Fig. 7) .
The Toll pathway induces immune responses necessary for clearance of pathogenic agents. One such immune effector is autophagy. Autophagy is a cellular process primarily involved in recycling cellular organelles in response to starvation but is also involved in the clearance of toxic aggregates and pathogens. A number of TLRs, namely TLR-4, TLR-7 and TLR-8, have been found to induce autophagy as a means of eliminating toxicity (53, 54) . In Drosophila, virus recognition by Toll-7 activates autophagy (55) . Furthermore, autophagy acts as a negative regulator of TLR-mediated inflammatory responses (56) and demonstrates crosstalk between these two pathways. Autophagy is implicated in several pathological conditions, including neurodegenerative diseases. Specifically, induction of autophagy was found to reduce toxicity in models of dominant expanded repeat diseases (50) (51) (52) , suggesting a protective role for autophagy in this context. Recently, nucleic acids have also been found to mediate the role of autophagy in heart inflammation and failure (57). Oka et al. (57) showed that mitochondrial DNA that escapes from autophagy leads to TLR-9-mediated inflammatory responses in cardiomyocytes and is capable of inducing myocarditis and dilated cardiomyopathy. Thus, a growing body of evidence suggests that perturbation in the metabolism of endogenous nucleic acids can initiate pathways with pathogenic consequences.
An increase in inflammatory factors, altered microglial cell activity and deregulation of Toll-like receptors (TLR) are all observed in healthy aging brains (58) . However, further perturbation of these inflammatory factors occurs in neurodegenerative diseases, including HD (58, 59) . Elevation of interleukin-6 (IL-6), a cytokine regulated by the Toll pathway, has been observed in preclinical HD mutant gene carriers, suggesting that abnormal immune activation may precede clinical pathology (23) . The observation of an increase in IL-10 in FXTAS preclinical individuals and a correlation between immune activation and repeat copy number further demonstrate the importance of immune activation in pathogenesis (24) . Additionally increased activation of microglia adjacent to degenerating neurons and upregulation of inflammatory cytokines have also been observed in post-mortem HD samples (60, 61) . Despite these observations, the role of neuroinflammation in pathogenesis is not fully understood. A simple explanation would be that neuroinflammation is a response to the neuronal toxicity caused by the mutant expanded repeats. Yet the elevated levels of IL-6 observed in preclinical HD individuals (23) and IL-10 observed in preclinical FXTAS individuals (24) suggest that immune activation precedes neuronal pathology. This implies that immune activation may be causative in pathogenesis rather than a consequence. Furthermore the level of immune activation has also been identified as an early indicator of prognosis. Specifically, heightened microglia activation has been correlated with a greater 5-year disease severity of preclinical HD patients (62, 63) . These findings collectively suggest that the expanded repeat mutations induce an immune response, which may in turn contribute to the resulting pathogenesis. The findings in this study propose that repeat-containing double-stranded RNA toxicity in glial cells is sufficient to cause non-autonomous toxicity leading to neurodegeneration. In summary, we have utilized Drosophila to model the human expanded repeat neurodegenerative diseases that include HD and found that rCAG.rCUG 100 RNA toxicity is dependent upon Toll signaling and is sensitive to autophagy. Since decreasing the activity of the Toll pathway reduces the observed toxicity, this pathway is an attractive target for potential therapeutic intervention. Double-stranded RNA exhibits the molecular and cellular hallmarks of HD-affected brain specific (CAG) 7 mer RNA and HD-mediated activation of innate immunity, and is, therefore, an ideal candidate pathogenic pathway for this group of human genetic diseases.
MATERIALS AND METHODS

Fly stocks
GMR-GAL4 (Bloomington stock #1104), P{GAL4-elav.L}2/ CyO (#8765 referred to as elavII-GAL4), repo-GAL4 (#7415),
RNAi (#34733), cact RNAi (#34775) and dl RNAi (#27650) were obtained from the Bloomington stock center. Atg1 RNAi (v16133) and Atg18
RNAi (v22646) were obtained from the Vienna Drosophila RNAi Center. LacZ RNAi was obtained from Richard Carthew (35) .
Transgenic fly lines
The generation of transgenic lines used in this study has previously been described (10, 11) . 4xUAS was generated in the attB system (64) and contains four independent insertions of the UAS construct with no repeats. 2xUAS contains two independent insertions of the UAS construct at the 22A and 58A loci. UAS contains a single insertion of the UAS construct at the 68E locus. The double-stranded RNA line rCAG.rCUG 100 S1 was used for a quantitative PCR. For microarray analysis rCAG.rCUG 100 S1 and rCAG.rCUG 100 S2 crossed to elavII-GAL4 were used. For genetic screening in the eye, the rCAG.rCUG 100
M3
line was crossed to GMR-GAL4 driver flies to generate male flies carrying both the driver and rCAG.rCUG 100 M3 . These flies were then crossed to each of the candidate RNAi lines to obtain the desired female progeny. rCAG.rCUG 100
W1
W2
were used for climbing assays and contain independent inserts of 1xrCAG 100 and 1xrCUG 100 
RNA purification and quantitative PCR
RNA from 50 heads from 1-day-old adult females was used in each sample for a quantitative PCR. RNA extraction and quantitative PCR were performed as described previously (11) . Expression levels were normalized to ribosomal protein 49 shows a significant increase in the percentage of flies that fail to climb at week 1 (n ¼ 18, P , 0.0001 and n ¼ 20, P , 0.0001, respectively) compared with the control (n ¼ 14). This phenotype in enhanced at week 2 (n ¼ 10, P , 0.0001 and n ¼ 16, P , 0.0001 respectively) compared with the control (n ¼ 13). Statistical analysis performed by two-way ANOVA and Bonferroni's multiple comparison tests.
* * * P , 0.0001, error bars show s.d. Control is 2×UAS.
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Rp49: GACGCTTCAAGGGACAGTATCTG/AAACGCGGT TCTGCATGAG, Repeat-containing transgene: TGTGGTGTGACATAATTG-GACAA/TGCTCCCATTCATCAGTTCC, Drosomycin: CGTGAGAACCTTTTCCAATATGATG/TCC CAGGACCACCAGCAT, Eiger:
CTGCTCGTGAATGCGATTCAT/TGCAGTATGC ACGATTCCGA.
Microarray analysis
The elavII-GAL4 pan-neuronal driver was used for this experiment. RNA was purified from heads of 1-day-old adult male heads as described above. Triplicate samples were used for each genotype (rCAG.rCUG 100 S1 , rCAG.rCUG 100 S2 and 4xUAS). Microarray analysis was performed using Affymetrix Drosophila 2.0 GeneChip w arrays and the quality of the RNA samples was verified by the Affymetrix Expression Console TM Software. Sample preparation, hybridization and detection were performed according to manufacturer's guidelines. Genes that showed a significant change in each of the doublestranded RNA lines (rCAG.rCUG 100 S1 or rCAG.rCUG 100 S2 ) compared with the control (4xUAS) (P , 0.05) but were unchanged between each other (P ≥ 0.05) were examined. The significance of each comparison was determined by a twotailed Student's t-test. The microarray data generated in these experiments are deposited in the GEO repository (NCBI) with accession number GSE42910.
Climbing assays
Climbing assays were performed as described previously (11) . Due to significant lethality of double-stranded RNA lines with repo-GAL4, only one replicate of flies was used for each genotype. Five trials were performed for each genotype at each time point (n ¼ 5). Two-way analysis of variance (ANOVA) and Bonferroni's multiple comparisons tests were performed (GraphPad Prism version 6.01 for Windows, GraphPad Software, La Jolla California, USA, www.graphpad.com) to compare the climbing ability of each genotype with the control and to determine the effect of aging. The significance threshold was set at P , 0.05.
Photography of eyes
At least 15 eyes of 1-day-old adult females were scored for each genotype and representative eyes were imaged using an Olympus SZX7 microscope fitted with a SZX-AS aperture along with an Olympus ColourView IIIU Soft Imaging System camera and AnalysisRuler image acquisition RNAi and (C ′ ) Atg18 RNAi enhance the rCAG.rCUG 100 phenotype. Experiments were performed at 258C. rCAG.rCUG 100 refers to rCAG.rCUG 100 M3 . Figure 7 . Model of toxicity caused by repeat-containing double-stranded RNA in Drosophila. Bidirectional transcription of expanded repeat disease genes produces repeat-containing rCAG.rCUG 100 double-stranded RNA (dsRNA). These dsRNA are cleaved by Dicer to small (rCAG) 7 (11, 12, 22) . In addition, an altered miRNA profile is observed. These small RNAs may activate the Toll pathway leading to an innate immune response. Increased toxicity in glial cells may cause glial cell death and eventual neurodegeneration. Results in this study indicate that pathogenesis is dependent on activation of the Toll pathway and toxicity in glial cells is sufficient to cause neurodegeneration. In addition, autophagy, an effector of the Toll pathway, plays a role in reducing pathogenesis by 'mopping-up' toxicity.
software.Photoshop 6.0 and Aperture 2.1.2 was used for image preparation. Anterior is to the left in all eye photos.
